In most cases having an enhanced MRI has no effect on hepatic hemangiomas; the MRI-enhanced contrast agent is quickly excreted and generally does not affect hepatic hemangiomas. When liver hemangiomas are scanned with MRI enhancement, the addition of contrast is usually required to show changes in the tumor and thus clarify whether it is a liver hemangioma. As a chemical, the contrast agent has a weak stimulating effect on the hepatic hemangioma lesion, so the enhanced MRI does not have much effect on the hepatic hemangioma. In addition, hepatic hemangioma is a benign tumor, so there is no possibility of malignant transformation of hepatic hemangioma stimulated by contrast medium. Moreover, the presence of hepatic hemangiomas in the contrast medium can better guide the development of subsequent treatment plans.